Edwards Lifesciences stock before the bell after a 0.0 percent move.

At the close on September 18, 2026, Edwards Lifesciences stock finished at USD 88.22 on the New York Stock Exchange. The shares were 8.3 percent below their 52-week high, with volume at 4.25 million shares.

Edwards Lifesciences stock closed at USD 88.22 on the New York Stock Exchange on September 18, 2026, down 0.01 percent. The move left the shares 8.3 percent below their 52-week high and 21.1 percent above their 52-week low.

September 18, 2026 in numbers

Edwards Lifesciences Corporation (ISIN US28176E1082, NYSE: EW) traded between USD 87.96 and USD 88.65 in the session, with volume of 4.25 million shares. The close sat just below the previous close implied by the reported 0.01 percent move, while the market capitalization was USD 50.80 billion as of September 18, 2026.

ad hoc news said the shares were supported by the company's July quarter, when Edwards Lifesciences reported EPS of USD 0.78 on revenue of USD 1.74 billion. The same report said the stock remained close to USD 88 after that earnings beat.

Pre-market on September 21, 2026

MarketBeat reported on September 20, 2026 that Edwards Lifesciences still had Q3 2026 guidance of USD 0.710 to USD 0.770 per share and FY 2026 guidance of USD 2.950 to USD 3.050 per share. That leaves investors with the latest dated company outlook heading into today's session.